Laboratory Contamination: 7 Common Sources,  Risks, and Prevention Strategies 

Contamination is one of the most pervasive threats to the reliability, reproducibility, and regulatory integrity of life science laboratory operations. While specific risks vary across research, clinical, pharmaceutical, biotechnology, and biosafety-level (BSL) laboratories, contamination generally occurs when unwanted biological, chemical, particulate, environmental, or informational material enters a laboratory, sample, process, or analytical system.  

For laboratory scientists and operators, contamination is much more than a housekeeping issue. It can alter cellular behavior, compromise assay performance, produce false-positive or false-negative results, invalidate experiments, damage instrumentation, result in the loss of irreplaceable samples, and potentially trigger significant regulatory or quality-system consequences. 

Understanding where contamination comes from - and how laboratory design, operations, maintenance, and personnel practices can help control it - is an important part of protecting both scientific integrity and laboratory operations. 

Understanding Relative Contamination Risk 

The frequency and potential impact of contamination varies significantly depending on its source: 

Laboratory Contamination Control Requires a Systems Approach 

Effective contamination control requires more than routine cleaning. It is a risk-based laboratory management system that incorporates facility design, personnel practices, equipment maintenance, environmental monitoring, workflow controls, and quality assurance. 

Core controls include: 

  1. Aseptic technique and personnel training appropriate to the laboratory’s activities. 

  2. Validated cleaning and disinfection procedures, including appropriate disinfectant selection and contact times. 

  3. Preventive maintenance of biosafety cabinets, HVAC systems, incubators, water systems, and critical laboratory equipment. 

  4. Environmental monitoring of air, surfaces, water, and other relevant media based on laboratory risk. 

  5. Routine mycoplasma testing where cell culture is performed. 

  6. Workflow segregation, particularly for activities such as pre- and post-PCR processing. 

  7. Controlled access, gowning, PPE, and personnel-flow procedures appropriate to the laboratory classification. 

  8. Validated sterilization and decontamination processes for critical equipment and materials. 

  9. Reagent and sample controls, including appropriate labeling, storage, segregation, and traceability. 

  10. Incident investigation and corrective and preventive action (CAPA) when contamination is detected. 

For laboratories operating under GMP, GLP, or other regulated quality systems, contamination control is also a regulatory and quality expectation. Laboratories must be able to demonstrate that environmental conditions, equipment, processes, and personnel practices are suitable for their intended use and that contamination events are detected, investigated, documented, and appropriately corrected. 

Protecting the Integrity of the Lab and the Science 

Laboratory contamination is best understood as a multifactorial systems risk, not simply a microbiological problem. Biological agents, personnel, airborne particles, samples, chemicals, water, equipment, building systems, utilities, reagents, and information-management processes can each compromise laboratory operations. 

The most effective contamination-control programs identify potential contamination pathways before an event occurs, establish controls proportional to the laboratory’s risk profile, continuously monitor critical conditions, and systematically investigate deviations when they occur. 

Ultimately, contamination control serves a straightforward objective: protecting the integrity of the sample, the validity of the experiment, the reliability of the data, and the scientific conclusions that depend on them. 

Previous
Previous

2026 Life Science Lab Fit-Out Costs: What Tenants Need to Know 

Next
Next

The Bottom of the Pyramid: Why Small Life Science Tenants Represent Big Demand